Valuation: Orion Oyj

Market Cap 14.29B 15.86B 13.21B 11.94B 22.59B 1,487B 23.14B 158B 63.08B 797B 59.52B 58.25B 2,535B P/E 2026 *
23.6x
P/E 2027 * 20.2x
Enterprise Value 14.18B 15.73B 13.1B 11.84B 22.4B 1,475B 22.95B 157B 62.56B 790B 59.03B 57.78B 2,514B EV / Sales 2026 *
6.73x
EV / Sales 2027 * 5.77x
Free-Float
90.18%
Yield 2026 *
1.91%
Yield 2027 * 2.26%
1 day-0.97%
1 week+3.24%
Current month+4.08%
1 month+28.14%
3 months+30.10%
6 months+49.12%
Current year+61.39%
1 week 50.5
Extreme 50.5
51.5
1 month 39.8
Extreme 39.8
51.5
Current year 31.6
Extreme 31.6
51.5
1 year 29.4
Extreme 29.4
51.5
3 years 15.2
Extreme 15.2
51.5
5 years 15.2
Extreme 15.2
51.5
10 years 15.2
Extreme 15.2
51.5
Manager TitleAgeSince
Chief Executive Officer 59 31/10/2022
Director of Finance/CFO 50 30/04/2024
Chief Operating Officer 46 31/12/2021
Director TitleAgeSince
Director/Board Member 63 21/03/2017
Director/Board Member 65 21/03/2017
Director/Board Member 66 05/05/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.97%+3.24% - - 15.94B
-0.32%+0.69%+44.43%+133.04% 1,276B
-0.85%+0.60%+43.42%+88.30% 676B
-0.42%-0.84%+29.84%+110.88% 519B
+0.02%+1.52%+39.21%+68.34% 388B
-1.07%-2.74%+60.79%+42.71% 365B
-1.29%-1.13%+27.54%+56.87% 307B
+0.09%-0.91%+3.19%+35.60% 287B
-0.27%-3.19%+36.86%+73.69% 252B
-0.49%-2.80%+38.37%+126.33% 212B
Average -0.58%+2.34%+35.96%+81.75% 476B
Weighted average by Cap. -0.52%+2.51%+38.70%+93.91%

Financials

2026 *2027 *
Net sales 2.11B 2.34B 1.95B 1.76B 3.33B 219B 3.41B 23.34B 9.3B 117B 8.78B 8.59B 374B 2.41B 2.67B 2.23B 2.01B 3.81B 251B 3.9B 26.68B 10.64B 134B 10.04B 9.82B 427B
Net income 608M 674M 561M 507M 960M 63.23B 984M 6.73B 2.68B 33.86B 2.53B 2.48B 108B 711M 789M 657M 594M 1.12B 73.98B 1.15B 7.87B 3.14B 39.62B 2.96B 2.9B 126B
Net Debt -117M -130M -108M -97.84M -185M -12.19B -190M -1.3B -517M -6.53B -488M -477M -20.78B -377M -419M -349M -315M -596M -39.28B -611M -4.18B -1.67B -21.03B -1.57B -1.54B -66.94B
Projected Income Statement - Annual - Orion Oyj
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,215
Date Price Change
11/11/26 €51.00 -0.97%
10/11/26 €51.50 +0.98%
09/11/26 €51.00 +0.99%
06/11/26 €50.50 -0.98%
05/11/26 €51.00 +3.24%
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Orion Oyj
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
101.90EUR
Average target price
87.50EUR
Spread / Average Target
-14.13%